ECSP13012613A - Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol - Google Patents

Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol

Info

Publication number
ECSP13012613A
ECSP13012613A ECSP13012613A ECSP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A
Authority
EC
Ecuador
Prior art keywords
gosipol
copolymer
producing
carboximetilcellulose
sound
Prior art date
Application number
Other languages
English (en)
Inventor
Felix Ivanovich Ershov
Vladimir Georgievich Nesterenko
Abdushukur Abdukhalilovich Sarymsakov
Natalya Uryevna Alekseeva
Original Assignee
Ltd Liability Company Nearmedic Plus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltd Liability Company Nearmedic Plus filed Critical Ltd Liability Company Nearmedic Plus
Publication of ECSP13012613A publication Critical patent/ECSP13012613A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/02—Alkyl or cycloalkyl ethers
    • C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
    • C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

La invención se refiere al campo de la química orgánica, la farmacología y la medicina y se refiere a un método para producir un copolímero de carboximetilcelulosa sódica y gosipol, que tiene la fórmula (I), así como también su uso en una terapia compleja para pacientes con trastornos del espectro autista y alteraciones cognitivas.
ECSP13012613 2010-10-11 2013-05-09 Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol ECSP13012613A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010141697/05A RU2453559C1 (ru) 2010-10-11 2010-10-11 Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями

Publications (1)

Publication Number Publication Date
ECSP13012613A true ECSP13012613A (es) 2013-10-31

Family

ID=45938511

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012613 ECSP13012613A (es) 2010-10-11 2013-05-09 Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol

Country Status (27)

Country Link
US (1) US9078916B2 (es)
EP (1) EP2628754B8 (es)
JP (1) JP5690944B2 (es)
CN (1) CN103189393B (es)
AU (1) AU2011314406B2 (es)
BR (1) BR112013008888B1 (es)
CA (2) CA2896450A1 (es)
CL (2) CL2013000962A1 (es)
CO (1) CO6731081A2 (es)
CY (1) CY1119413T1 (es)
DK (1) DK2628754T3 (es)
EA (2) EA024810B1 (es)
EC (1) ECSP13012613A (es)
ES (1) ES2643167T3 (es)
GE (1) GEP201706607B (es)
HR (1) HRP20171330T1 (es)
HU (1) HUE034920T2 (es)
LT (1) LT2628754T (es)
PE (1) PE20140200A1 (es)
PL (1) PL2628754T3 (es)
PT (1) PT2628754T (es)
RS (1) RS56257B1 (es)
RU (1) RU2453559C1 (es)
SI (1) SI2628754T1 (es)
SM (1) SMT201700497T1 (es)
UA (2) UA108126C2 (es)
WO (1) WO2012050483A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2499002C1 (ru) * 2012-06-14 2013-11-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе
RU2577539C2 (ru) * 2014-06-17 2016-03-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Полимерные производные госсипола, способ их получения и фармацевтическая композиция на их основе
RU2754067C2 (ru) * 2018-05-18 2021-08-25 Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение
RU2746504C1 (ru) * 2020-02-27 2021-04-14 Ниармедик Интернэшнл Лимитед Противомикробные средства на основе бета-глюканов, способы их получения и применения
CN114622407B (zh) * 2022-04-01 2023-09-19 浙江隆腾医用新材料有限公司 一种羧甲基纤维素钠纤维的洗脱方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2002755C1 (ru) * 1991-02-04 1993-11-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Производное целлюлозы и госсипола, обладающее интерферониндуцирующим и противовирусным действием
RU2222548C2 (ru) * 2000-07-21 2004-01-27 Зао "Ниармедик Плюс" Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе
BR0311693A (pt) * 2002-06-10 2005-03-22 Wyeth Corp Sal de formato de o-desmetil-venlafaxina
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
RU2238122C1 (ru) * 2003-01-20 2004-10-20 Ооо "Ниармедик Плюс" Противоинфекционный фармацевтический препарат
RU2270708C1 (ru) * 2004-05-26 2006-02-27 Ооо "Ниармедик Плюс" Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний
US20060144723A1 (en) * 2004-11-02 2006-07-06 Mary Fuller Device for securing valuables
US20070148238A1 (en) * 2005-06-23 2007-06-28 Spherics, Inc. Dosage forms for movement disorder treatment
US20090285865A1 (en) * 2008-05-14 2009-11-19 Shalaby Shalaby W Palatable, solid oral formulations for male chemical sterilization

Also Published As

Publication number Publication date
CO6731081A2 (es) 2013-08-15
EP2628754A1 (en) 2013-08-21
PE20140200A1 (es) 2014-02-21
AU2011314406B2 (en) 2016-08-11
CL2013000962A1 (es) 2013-12-06
DK2628754T3 (da) 2017-11-20
EP2628754A4 (en) 2014-03-26
CY1119413T1 (el) 2018-03-07
RU2010141697A (ru) 2012-04-20
LT2628754T (lt) 2017-11-10
CA2896450A1 (en) 2012-04-19
UA108126C2 (uk) 2015-03-25
GEP201706607B (en) 2017-01-25
CN103189393B (zh) 2015-09-30
WO2012050483A1 (ru) 2012-04-19
RU2453559C1 (ru) 2012-06-20
EP2628754B8 (en) 2017-10-25
RS56257B1 (sr) 2017-11-30
BR112013008888B1 (pt) 2021-01-05
EA201690544A1 (ru) 2016-07-29
EP2628754B1 (en) 2017-07-12
AU2011314406A1 (en) 2013-05-23
CN103189393A (zh) 2013-07-03
US20130266534A1 (en) 2013-10-10
JP2013540866A (ja) 2013-11-07
CA2811583C (en) 2016-03-22
PL2628754T3 (pl) 2017-12-29
EA024810B1 (ru) 2016-10-31
PT2628754T (pt) 2017-10-19
SI2628754T1 (en) 2017-11-30
BR112013008888A2 (pt) 2016-06-28
SMT201700497T1 (it) 2017-11-15
CL2015001180A1 (es) 2015-08-28
US9078916B2 (en) 2015-07-14
EA201390530A1 (ru) 2013-07-30
CA2811583A1 (en) 2012-04-19
HRP20171330T1 (hr) 2017-10-20
JP5690944B2 (ja) 2015-03-25
HUE034920T2 (en) 2018-03-28
EA031316B1 (ru) 2018-12-28
UA108975C2 (uk) 2015-06-25
ES2643167T3 (es) 2017-11-21

Similar Documents

Publication Publication Date Title
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
PY1337526A (es) Métodos para tratar o prevenir asma administrando un antagonista de IL-4R.
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
CR20140512A (es) Dispositivos y metodos para la fabricación de aditivos de componentes de implante
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
EA201171367A1 (ru) Винилиндазолильные соединения
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
EA201400178A1 (ru) Лечение рака молочной железы
UY33735A (es) Compuestos antivirales
BR112015020389A2 (pt) compostos carbazol úteis como inibidores de bromodomínio
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
EA201490546A1 (ru) Замещенные аннелированные пиримидины и их применение
CU24263B1 (es) Derivados de imidazopiridazinas inhibidores de quinasa akt, útiles para el tratamiento del cáncer
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
MX360554B (es) Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2.
CL2011002090A1 (es) Complejo de haluro de agomelatina, que corresponde a un derivado de naftaleno; procedimiento de preparacion del mismo.
FI20115135A0 (fi) Mikrofibrilloidun selluloosan tulehduksia estävä vaikutus
EA201200046A1 (ru) Новые соединения, фармацевтическая композиция и связанные с ними способы
MX2015014344A (es) Terapia contra el cancer.
GT201200345A (es) Compuestos heterocìclicos, su preparaciòn y su aplicaciòn terapèutica
DOP2014000114A (es) Nuevos 2h–indazoles como antagonistas del receptor ep2
MX2016001384A (es) Metodos para incrementar el volumen espiratorio forzado en pacientes asmaticos que usan benralizumab.
ECSP13012613A (es) Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol
UY34543A (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica.